Excitement over anticipated approval of T-20 is balanced by fears that it will be the most expensive HIV drug yet
13 October 2002. Related: Treatment access.
Treatment access
GlaxoSmithKline cuts drug prices to 63 countries
13 October 2002. Related: Treatment access.
Bill Clinton and Nelson Mandela promise to lead peer education among political leaders as world looks for $10 billion a year to fight HIV/AIDS
11 September 2002. Related: Conference reports, Treatment access.
South African activist unveils campaign to force compulsory licences
11 September 2002. Related: Conference reports, Treatment access.
MSF study shows treatment in resource-poor settings is effective
11 September 2002. Related: Conference reports, Treatment access.
‘Barcelona Declaration’ demands 2m poor people are treated in the next two years
11 September 2002. Related: Conference reports, Treatment access.
Lives were lost as experts argued the merits of care versus prevention, says Stefano Vella
11 September 2002. Related: Conference reports, Treatment access.
Peter Piot sets out the global political agenda in the fight against HIV/AIDS
11 September 2002. Related: Conference reports, Treatment access.
Health should be a right, not a commodity, and medicine must be removed from the World Trade Organisation, argues key speaker
11 September 2002. Related: Conference reports, Treatment access.
Governments must act to cut drug prices, says Kenya’s health minister
11 September 2002. Related: Conference reports, Treatment access.
Civil society had to fight for universal access to AIDS drugs in Brazil
11 September 2002. Related: Conference reports, Treatment access.
Coalitions of local NGOs can effectively demand access to medicines, reports MSF
11 September 2002. Related: Conference reports, Treatment access.
Involvement of PLWHA is key to improving access to treatments
11 September 2002. Related: Conference reports, Treatment access.
ART can successfully tackle advanced disease in resource poor settings, reports MSF
11 September 2002. Related: Conference reports, Treatment access.
Investment in treatment and care significantly reduces company health and social expenditure in Abidjan
11 September 2002. Related: Conference reports, Treatment access.
Financing the global response to the epidemic will cost $9.2 billion a year, according to one estimate
11 September 2002. Related: Conference reports, Treatment access.
The Global Fund: what, where, how much?
11 September 2002. Related: Conference reports, Treatment access.
Leading businesses spurn Global Fund
11 September 2002. Related: Conference reports, Treatment access.
14 Caribbean governments sign cut-price drugs agreement with six pharmaceutical companies
11 September 2002. Related: Conference reports, Treatment access.
Thailand offers low-cost transfer to African countries of technology for the local production of generic antiretrovirals
11 September 2002. Related: Conference reports, Treatment access.
Informal market plays a role in distributing antiretrovirals but exposes clients to risks
11 September 2002. Related: Conference reports, Treatment access.
Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1
11 July 2002. Related: Treatment access.
US foundation bars GlaxoSmithKline representatives over AIDS drug pricing
11 July 2002. Related: Treatment access.
WHO releases guidelines for use of antiretroviral drugs to treat HIV infection in developing countries (2002)
11 June 2002. Related: Treatment access.
Mbeki backs down: he shuns dissidents and expands drug treatment programme
11 June 2002. Related: Treatment access.
Early access programme offers adefovir for treatment of HBV
11 June 2002. Related: Treatment access.
South Africa finds 1 billion Rand to treble HIV budget, after Mandela confronts Mbeki
10 April 2002. Related: Treatment access.
Meeting calls for NHS funding and training to provide repair treatment for people with facial lipoatrophy
10 March 2002. Related: Special reports, Treatment access, Side effects, Weight, diabetes, metabolic complications.
South African treatment activists defy patent laws to import generic antiretrovirals from Brazil
10 March 2002. Related: Treatment access.
Survey reveals pregnant Zambians support universal nevirapine treatment
9 December 2001. Related: Treatment access.
Drug companies’ spending on advertising double research and development spending in 2000
1 September 2001. Related: Treatment access.
Nigeria to launch AIDS treatment program
1 September 2001. Related: Treatment access.
Abbott Labs cuts prices on many drugs, treatments amid pricing investigation
30 July 2001. Related: Treatment access.
Yale economist introduces proposal to settle debate between pharmaceutical companies and developing nations
30 July 2001. Related: Treatment access.
Kenyan lawmakers approve bill to suspend drug patent rights and improve cheaper drug access
30 July 2001. Related: Treatment access.
South African government issues first draft of legislation allowing importation of discounted pharmaceuticals
30 July 2001. Related: Treatment access.
International aid group to begin administering AIDS drugs to small group of poor South Africans
30 July 2001. Related: Treatment access.
Britain to Donate £75 million to global AIDS fund
30 July 2001. Related: Treatment access.
Uganda to offer free HIV drugs to pregnant women to prevent vertical HIV transmission
30 July 2001. Related: Treatment access, Pregnancy.
Cipla announces plan to manufacture 3-in-1 HIV pil
30 June 2001. Related: Treatment access.
Huge mining firm to provide African employees with AIDS medications
30 June 2001. Related: Treatment access.
South African Department of health has not killed possibility of AIDS drug provision, letter says
30 June 2001. Related: Treatment access.
Government, pricing not the only problems
30 June 2001. Related: Treatment access.
South Africa AIDS drug settlement may not signify immediate influx of drugs
30 June 2001. Related: Treatment access.
AIDS crisis has Sspurred public relations challenges for pharmaceutical industry, Wall Street Journal reports
30 June 2001. Related: Treatment access.
Drug companies withdraw HIV drug lawsuit against South Africa
17 May 2001. Related: Treatment access.
Ethiopia to import AIDS drugs for first time
17 May 2001. Related: Treatment access.
AIDS care for Africa affordable
17 May 2001. Related: Treatment access.
Tony Blair sides with drug giants
17 May 2001. Related: Treatment access.
South African court battle damages drug industry’s image
17 April 2001. Related: Treatment access.
Red Cross slams drug firms over pricing policies
17 April 2001. Related: Treatment access.
Medecins Sans Frontieres urges drugs giants to drop South Africa suit
17 April 2001. Related: Treatment access.
Second Indian firm offers cut-price HIV drugs
17 April 2001. Related: Treatment access.
Yale pressed to help cut drug costs in Africa
17 April 2001. Related: Treatment access.
GlaxoSmithKline offers 90% discount on HIV drugs to Africa
17 April 2001. Related: Treatment access.
HIV drug prices cut for poorer countries
17 April 2001. Related: Treatment access.
Bristol-Myers Squibb offers to sell AIDS drugs in Africa at below cost
17 April 2001. Related: Treatment access.
Roche and Trimeris announce US sites and investigators for T-20 phase III study; activists want wider access to drug for sickest AIDS patients
17 April 2001. Related: Antiretrovirals, Treatment access.
European activists demand greater access to T-20
17 April 2001. Related: Treatment access.
From talk to action in fighting AIDS in the developing countries: 8th Retrovirus Conference opening session
17 March 2001. Related: Conference reports, Treatment access.
UNAIDS calls for new deal between pharmaceutical companies and society
17 March 2001. Related: Treatment access.
US trade action threatens Brazilian AIDS programme
17 March 2001. Related: Treatment access.
Brazil may flout trade laws to keep AIDS drugs free for patients
17 March 2001. Related: Treatment access.
Roche open to discuss patent rights of AIDS drug with Brazil
17 March 2001. Related: Treatment access.
Crusading Indian firm takes on might of Glaxo SmithKline: Cipla offers anti-HIV drugs at a fraction of rivals’ prices
17 March 2001. Related: Treatment access.